Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster presentation 1

1335 - Analysis of mutations of EGFR gene in non-small cell lung cancer from patients in Siberian part of Russia


19 Dec 2015


Poster presentation 1


Vladimir Shamanin


Annals of Oncology (2015) 26 (suppl_9): 8-15. 10.1093/annonc/mdv518


V. Shamanin1, I. Karpov1, S. Kovalenko2, N. Gutkina2

Author affiliations

  • 1 R&d, BioLink Ltd, 630117 - Novosibirsk/RU
  • 2 -, Institute of Molecular Biology and Biophysics SB RAMS, 630117 - Novosibirsk/RU


Abstract 1335


About 15% of non-small cell lung cancer (NSCLC) cases carry activating mutations in the EGFR gene which are associated with high sensitivity of the tumor to tyrosine kinase inhibitors. Frequency of the mutations positively correlates with adenocarcinoma (AdCa) histology, female gender, non-smoker status and Asian ethnicity. Most of activating mutations in EGFR gene (85-90%) are small in-frame deletions in exon 19 (del19), or missense mutation L858R. Population in Russia is composed of Caucasian and Asian ethnic groups which may have impact on frequency of EGFR mutations. Aim of the study was to evaluate frequency of EGFR mutations del19 and L858R in archive FFPE tumor tissue from NSCLC patients in Siberian part of Russia.


Archive FFPE samples were provided by clinics from 9 largest cities in East and West Siberia. DNA purification and EGFR mutation tests were done in one laboratory (Biolink Ltd, Novosibirsk). Mutation L858R was detected by allele-specific real-time PCR. Mutations del19 were detected by wild-type blocking (WTB) real-time PCR. Sequence of del19 mutations was determined by Sanger sequencing of the WTB PCR DNA.


Sensitivity of PCR tests was 1% mutant EGFR allele in 10ng of tissue DNA spiked with plasmid DNA with the mutation. A total of 400 FFPE samples were evaluated and DNA from 382 samples (95,5%) were suitable for the tests including 35 cases of squamous cell carcinoma (SCC), 249 AdCa and 96 cases with mixed histology. EGFR mutations were detected in 63 cases (16,5%) including 34 cases of del19 and 29 cases of L858R. EGFR mutations were much more frequent among female patients (39%) in comparison to male (6%). Mutations were also much more common in AdCa (22%) in comparison to SCC (3%).


Frequency of EGFR mutations in NSCLC cases in Siberia is in agreement with studies in Western Europe. Study was supported by FASIE grant 12594р/24404 and RSF grant 15-14-10004.


All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings